Results 121 to 130 of about 1,504 (179)

As carreiras da cloroquina e da hidroxicloroquina como medicamentos “milagrosos” contra a Covid-19: narrativas da França e do Brasil

open access: yes
In early January 2024, a widely publicized article in the journal Biomedicine and Pharmacology estimated that approximately 17,000 COVID-19 patients in France, Italy, Spain, Turkey, and the US died as a result of hydroxychloroquine treatment.
Osorio-de-Castro, Claudia Garcia Serpa   +3 more
core  

PREVALENCE AND RISK FACTORS ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON HYDROXYCHLOROQUINE: A POPULATION-BASED STUDY. [PDF]

open access: yesArq Gastroenterol
Boustany A   +11 more
europepmc   +1 more source

Evidence syntheses to support decision-making related to the Covid-19 pandemic. [PDF]

open access: yesRev Saude Publica
Andrade KRC   +14 more
europepmc   +1 more source

[Ischaemic stroke associated with COVID-19 in dialysis patients]. [PDF]

open access: yesNefrologia, 2021
de Lorenzo A   +6 more
europepmc   +1 more source

[Relation between COVID-19 and Guillain-Barré syndrome in adults. Systematic review]. [PDF]

open access: yesNeurologia, 2020
Trujillo Gittermann LM   +2 more
europepmc   +1 more source

Whipple's Disease as a Differential Diagnosis of Blood Culture-Negative Endocarditis: A Case Report. [PDF]

open access: yesArq Bras Cardiol
Soares CK   +5 more
europepmc   +1 more source

[Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19]. [PDF]

open access: yesMed Clin (Barc), 2020
Monte Serrano J   +3 more
europepmc   +1 more source

QT interval prolongation in geriatric patients treated for SARS-COV-2 infection: OCTA-COVID study. [PDF]

open access: yesMed Clin (Barc), 2021
Garmendia-Prieto B   +2 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy